Technologies by Adegboyega Oyelere
Small Molecule Glycosylated Histone Deacetylase Inhibitors (HDACi)
A targeted potential therapy for liver cancer
A targeted potential therapy for liver cancer
8373
New Class of Tissue-Targeting Agents Inhibits Fibrosis, Inflammation, and Cancer Growth
A 1,000x more potent idiopathic pulmonary fibrosis (IPF) treatment than currently available
A 1,000x more potent idiopathic pulmonary fibrosis (IPF) treatment than currently available
8374
Tissue-Selective Anticancer Agents
Targeted HDAC inhibitors that potently suppress hepatocellular solid tumor growth
Targeted HDAC inhibitors that potently suppress hepatocellular solid tumor growth
4195
Novel Pharmaceutical Compounds Based on Tumor-Selective KDM Inhibitors
Can inhibit cell growth with dramatically enhanced cytotoxic potency for triple negative breast cancer
Can inhibit cell growth with dramatically enhanced cytotoxic potency for triple negative breast cancer
7880
Therapeutic Compounds for Prostate Cancer Treatment
Potent histone deacetylase (HDAC) inhibitors that can be used to treat or prevent prostate tumors
Potent histone deacetylase (HDAC) inhibitors that can be used to treat or prevent prostate tumors
5394